Bioventus (US:BVS) — Company Overview, News & Financial Data
Bioventus specializes in orthobiologics and therapies for bone healing and knee osteoarthritis.
BVSBioventus
Company profile
About Bioventus
Bioventus (NASDAQ:BVS) focuses on innovating and delivering products that help people heal and resume their active lifestyles. The company specializes in orthobiologics, surgical, and non-surgical therapies aimed at bone healing, bone graft, and knee osteoarthritis among other musculoskeletal conditions. With a strong commitment to high-quality clinical research, Bioventus aims to provide effective solutions that support the body’s natural healing processes. Their projects range from developing innovative treatment options to expanding their global reach to help more patients around the world. The objective of Bioventus is to improve the lives of people suffering from joint and musculoskeletal issues, driving forward with the goal of becoming a trusted leader in their specialized field.
Snapshot
Public USOwnership
2011Year founded
970Employees
North Carolina, United StatesHead office
Loading Map...
Global footprint
Operations
All Locations
United States
Products and/or services of Bioventus
- EXOGEN Ultrasound Bone Healing System, a device that uses low-intensity pulsed ultrasound to stimulate bone healing.
- DUROLANE, a single injection hyaluronic acid product for treating knee osteoarthritis pain.
- GELSYN-3, a three-injection regimen for knee osteoarthritis, providing pain relief and improved function.
- SUPARTZ FX, a series of injections intended to replace knee joint fluid, reducing osteoarthritis pain and improving mobility.
- Bioventus Surgical, offering bone graft solutions like OSTEOAMP for spinal fusion surgeries, enhancing bone growth and healing.
- SIGNAFUSE Bioactive Bone Graft, a product supporting bone repair by incorporating bioactive glass into a resorbable binder.
Bioventus executive team
- Mr. Robert E. ClaypoolePresident, CEO & Director
- Mr. Mark L. SingletonSenior VP & CFO
- Mr. Anthony D'Adamio J.D.Senior VP, General Counsel & Corporate Secretary
- Mr. Mike Crowe B.S., M.B.A.Senior Vice President of Operations
- Mr. David CrawfordVice President of Investor Relations & Treasurer
- Ms. Katrina J. Church J.D.Senior VP & Chief Compliance Officer
- Ms. Helen LeupoldSenior VP & Chief Human Resources Officer
- Mr. Dave VennerSenior VP & GM of Surgical